BGM Group Ltd. (BGM): Net Income
-$19.94M
Year ended 2025-09-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | -$19.94M | n/m | 2026-07-21, From 2024-10-01 |
| 2024-09-30 | -$1.44M | n/m | 2026-07-21, From 2023-10-01 |
| 2023-09-30 | -$7.78M | n/m | 2026-07-21, From 2022-10-01 |
| 2022-09-30 | $1.08M | -65.9% | 2025-04-03, From 2021-10-01 |
| 2021-09-30 | $3.15M | -37.7% | 2024-02-15, From 2020-10-01 |
| 2020-09-30 | $5.06M | n/c | 2023-04-19, From 2019-10-01 |
| 2019-09-30 | $5.91M | +13.6% | 2022-10-13, From 2018-10-01 |
| 2018-09-30 | $5.20M | n/a | 2021-03-09, From 2017-10-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| BGM Group Ltd. (BGM) | 2025-09-30 | -$19.94M | n/m |
| Lftd Partners Inc. (LIFD) | 2025-12-31 | -$24.86M | n/m |
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | -$5.98M | n/m |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $3.63M | +11.6% |
| Verrica Pharmaceuticals Inc. (VRCA) | 2025-12-31 | -$17.89M | n/m |
| Bioharvest Sciences Inc. (BHST) | 2025-12-31 | -$11.13M | n/m |
| Biofrontera Inc. (BFRI) | 2025-12-31 | -$10.54M | n/m |
| Wave Life Sciences, Inc. (WVE) | 2025-12-31 | -$204.38M | n/m |
| Xilio Therapeutics, Inc. (XLO) | 2025-12-31 | -$35.04M | n/m |
Compare BGM, LIFD, SBFM, ETST side by side · Screen every company in Pharmaceutical Preparations ↗